Plasma cell-free RNA ITGB3 is associated with long-term clinical benefit in patients with non-small cell lung cancer receiving immunochemotherapy 14 de October de 2026 by Yu, Y., Liu, Y., Zhang, X., Yang, W., Hou, S., Yu, W., Zhang, F., Yu, B., Hu, Z., Wu, Z., Huang, S., Wang, J.
Yu, Y., Liu, Y., Zhang, X., Yang, W., Hou, S., Yu, W., Zhang, F., Yu, B., Hu, Z., Wu, Z., Huang, S., Wang, J. 